Histological staining indicated that sh‐BCL2L11 enhanced the protective effects of EVs on reducing infarction area, improving myocardial damage, and reducing fibrotic areas and TUNEL‐positive cells, while BCL2L11 overexpression caused opposite consequences (Figure 5B through 5E). Here, BCL2L11 is linked to infarction.